A plant-based diet may reduce cardiovascular risk in people with HIV. Despite a downward trend, there remains a high rate of first-time prescriptions of benzodiazepines in older adults. Researchers have developed a novel blood test that can diagnose a heart attack within minutes. A study found a comparable reduction in LDL-C with statins and bempedoic acid in patients with and without ASCVD. COVID-19 infection may increase the risk of heart attack, stroke and all-cause mortality up to three years post-infection. Commonly used arm positions with a person's arm at their side or on their lap result in a significant overestimation of BP. BridgeBio Pharma announced this week outcomes from the ATTRibute-CM study will be shared at AHA 2024. A study demonstrated long-term safety and efficacy of the GORE CARDIOFORM ASD Occluder. Bridge Bio Pharma presented results from a post-hoc analysis which demonstrated the efficacy of acoramidis in ATTR-CM. Théophile Mohr-Durdez, CEO and co-founder of Volta Medical, talks about streamlining workflows for electrophysiologists. The MATTERHORN trial demonstrates that, for patients with HF and FMR, M-TEER is non-inferior to surgical mitral valve repair. The RESHAPE-HF2 trial offers further insights into the transcatheter management of patients with HFrEF and FMR. The CardioNerds and colleagues from MedStar Health discuss an usual case of cobalt cardiomyopathy. An AI-enabled stethoscope can help physicians identify twice as many cases of heart failure compared to usual obstetric care. Researchers have developed a machine learning model which can identify people who are likely to have elevated Lp(a). Bempedoic acid treatment is similarly effective at lowering low-density lipoprotein cholesterol compared with statins. People who quit smoking have a lower risk of atrial fibrillation than people who continue to smoke. The SENIOR-RITA trial investigates the optimal management strategy for older adults with NSTEMI. The EPIC-CAD trial addresses a crucial question in managing patients with both atrial fibrillation and stable CAD. The SCOFF trial challenges the long-standing practice of fasting before cardiac catheterization procedures.